Dietary interventions for multiple sclerosis-related outcomes.
CONCLUSIONS: There are a variety of controlled trials addressing the effects of dietary interventions for MS with substantial variation in active treatment, comparator, and outcomes of interest. PUFA administration may not differ when compared to alternatives with regards to relapse rate, disability worsening, or overall clinical status in people with MS, but evidence is uncertain. Similarly, at present, there is insufficient evidence to determine whether supplementation with antioxidants or other dietary interventions have any impact on MS-related outcomes.
PMID: 32428983 [PubMed - in process]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Parks NE, Jackson-Tarlton CS, Vacchi L, Merdad R, Johnston BC Tags: Cochrane Database Syst Rev Source Type: research
More News: Antidoxidants | Clinical Trials | Complementary Medicine | Databases & Libraries | Diets | Disability | General Medicine | International Medicine & Public Health | Middle East Health | MRI Scan | Multiple Sclerosis | Nutrition | Omega 3 | Omega 6 | Probiotics | Science | Study | Vitamin B2 | Vitamin B7 | WHO